Cellular factor affecting the stability of beta-globin mRNA.
Messenger RNAs in eukaryotic cells exhibit a broad range of stabilities in vivo. Globin mRNA has a half life in excess of 50 h, but the half life of the c-myc oncogene mRNA is less than 20 min. Regulation of gene expression may be accomplished by a variety of mechanisms, including altering mRNA stability. We have examined the nuclear and cytoplasmic fractions of cells for factors affecting the metabolism of mRNA. Here we report that a HeLa whole-cell extract contains a factor that protects beta-globin mRNA from attack by RNases in a mouse erythroleukemia cell cytoplasmic extract. The factor is non-dialysable, inactivated by proteinase K and heat treatment, and resistant to RNase and DNase digestion. The HeLa cell factor resembles placental RNase inhibitor in that the mRNA-protecting activity is effective against RNase A and that treatment of the extract with N-ethylmaleimide completely destroys the protective activity. However, purified placental RNase inhibitor was unable to inhibit the RNase activity in the MELC cytoplasmic extract. These results suggest that the HeLa cell extract contains an RNase inhibitor (or inhibitors) with an activity or specificity that is distinct from that of placental RNase inhibitor.
Stolle
C A
CA
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510.
Benz
E J
EJ
D002460:Cell Line; D002474:Cell-Free System; D005033:Ethylmaleimide / Q000494:pharmacology; D005914:Globins / Q000235:genetics*; D006207:Half-Life; D006367:HeLa Cells / Q000032:analysis*; D004915:Leukemia, Erythroblastic, Acute / Q000201:enzymology; D009363:Neoplasm Proteins / Q000378:metabolism; D010920:Placenta / Q000032:analysis; D012315:RNA Caps / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism*; D012260:Ribonucleases / Q000037:antagonists & inhibitors*
D009363:Neoplasm Proteins; D012315:RNA Caps; D012333:RNA, Messenger; D005914:Globins; D012260:Ribonucleases; D005033:Ethylmaleimide